MedPath

The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay May Improve ICSI Outcome.

Not Applicable
Active, not recruiting
Conditions
Fertility Issues
Interventions
Procedure: Sperm selection by IMSI
Procedure: Sperm selection by IMSI and spermslow
Registration Number
NCT06156722
Lead Sponsor
Meir Medical Center
Brief Summary

In this prospective randomized sibling-oocytes blinded study, investigators examine the combination of two sperm selection methods that logically seem to complete each other, and potentially may improve ICSI outcomes.

The methods include the selection of the optimal spermatozoa based on its morphology by IMSI, together with its physiological function of binding to HA by Spermslow (SS).

The current study compared a group of ET after sperm selection by IMSI with SS to a group of ET after sperm selection by IMSI-only without SS, and to a mixed ET group where two embryos were transferred, one after IMSI-only and the other one after IMSI with SS.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
189
Inclusion Criteria

females ages 38 or younger retrieval of at least 5 mature oocytes and fresh ejaculate samples

Read More
Exclusion Criteria

frozen embryos surgically extracted sperm preparations embryo-biopsy cycles

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
The IMSI-only groupSperm selection by IMSIThe IMSI-only group
IMSI with SpermSlow groupSperm selection by IMSI and spermslowIMSI with SpermSlow group
Primary Outcome Measures
NameTimeMethod
Pregnancy and delivery ratesWithin up to 10 month from treatment

Pregnancy and delivery rates

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Meir Medical Center

🇮🇱

Kfar Saba, Israel

© Copyright 2025. All Rights Reserved by MedPath